Combined sample-to-report solution pairs PacBio HiFi WGS with GenomOncology Pathology Workbench to support clinical labs in delivering configurable, reimbursement-aligned genomic...
CLEVELAND, March 10, 2026 /PRNewswire/ — GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered...
CLEVELAND, Jan. 14, 2026 /PRNewswire/ — GenomOncology (GO), a leader in precision medicine reporting solutions, today announced a strategic partnership with Oregon...
CLEVELAND and DURHAM, N.C., Nov. 11, 2025 /PRNewswire/ — GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic...
CLEVELAND, April 10, 2025 /PRNewswire/ — GenomOncology today announced BioMCP, a new open-source technology that helps artificial intelligence (AI) systems access specialized...
CLEVELAND, March 31, 2025 /PRNewswire/ — GenomOncology, a precision medicine software company, today announced a strategic partnership with Chronetyx Laboratories, a leading...
CLEVELAND, March 25, 2025 /PRNewswire/ — Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that...
Clinicians experience a spike in suggested treatment changes and increase in precision medicine and clinical trial referrals. (Canton, Mass.) –...
CLEVELAND and CAMBRIDGE, Mass., Feb. 13, 2025 /PRNewswire/ — GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicine™, today...
GenomOncology is proud to announce the appointment of Dr. Jonathan “Jack” Lord, M.D., to its Board of Directors. A nationally...
GenomOncology, a precision medicine software company, and Genomenon, a leading genomic intelligence company, today announced a strategic partnership aimed at...
At GenomOncology, we’re committed to empowering the healthcare community with data-driven insights that improve cancer care. Our precision medicine software...
